Cargando…

Endocrinological Testicular Dysfunction in Patients with Lepromatous Leprosy and the Impact of Disease on Patient's Quality of Life

INTRODUCTION: Leprosy or Hansen's disease poses a drastic impact on the quality of life in affected patients even after successful completion of treatment. The involvement of the endocrine system in leprosy is usually insidious, silent, and under-reported, especially the testicular dysfunction....

Descripción completa

Detalles Bibliográficos
Autores principales: Mohta, Alpana, Agrawal, Aditi, Sharma, Pritee, Singh, Arti, Garg, Smiley, Kushwaha, Ramesh Kumar, Jain, Suresh Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735009/
https://www.ncbi.nlm.nih.gov/pubmed/33344347
http://dx.doi.org/10.4103/idoj.IDOJ_287_20
_version_ 1783622582137782272
author Mohta, Alpana
Agrawal, Aditi
Sharma, Pritee
Singh, Arti
Garg, Smiley
Kushwaha, Ramesh Kumar
Jain, Suresh Kumar
author_facet Mohta, Alpana
Agrawal, Aditi
Sharma, Pritee
Singh, Arti
Garg, Smiley
Kushwaha, Ramesh Kumar
Jain, Suresh Kumar
author_sort Mohta, Alpana
collection PubMed
description INTRODUCTION: Leprosy or Hansen's disease poses a drastic impact on the quality of life in affected patients even after successful completion of treatment. The involvement of the endocrine system in leprosy is usually insidious, silent, and under-reported, especially the testicular dysfunction. AIMS AND OBJECTIVES: The present study was aimed at evaluating the abnormalities of the primary testicular hormone testosterone and the gonadotrophins LH and FSH in male patients affected with lepromatous leprosy and assessing the impact of the disease on quality of life (QOL). MATERIALS AND METHODS: The study included 43 married male patients diagnosed with lepromatous leprosy. Careful history taking and examination for symptoms of testicular dysfunction were done. Serum concentrations of total testosterone, FSH, and LH were noted. The QOL was evaluated using the WHO Quality of Life-BREF (WHOQoL-BREF). RESULTS: The most common clinical manifestation of testicular dysfunction was reduced or loss of libido reported in 12 (27.9%) patients followed by gynaecomastia in 7 (16.3%). Ultrasonographic (USG) analysis revealed reduced testicular volume in 31 (72.1%) patients, and average testicular volume was 11.9 ± 4.9 mL each. Seventeen (39.5%) patients had low serum testosterone levels, 9 (20.9%) had high serum FSH level, and 11 (25.6%) high LH levels. There was a significant negative correlation between testosterone level and FSH as well as LH. There was also a significantly positive correlation between testicular volume and testosterone level. Symptomatic patients with gynaecomastia/gynaecothelia had higher hormonal derangement than those who had other symptoms. On QOL, most patients scored lowest on the domain of “social relationships” (including sexual wellbeing) followed by “psychological health”. CONCLUSION: We found a high rate of USG diagnosed testicular atrophy in lepromatous leprosy patients. Therefore, every leprosy patient should be thoroughly examined clinically to rule out features of testicular dysfunction. Testicular function tests should be routinely carried out in all leprosy patients to arrive at an early diagnosis. Leprosy is found to affect all domains of a patient's quality of life.
format Online
Article
Text
id pubmed-7735009
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-77350092020-12-18 Endocrinological Testicular Dysfunction in Patients with Lepromatous Leprosy and the Impact of Disease on Patient's Quality of Life Mohta, Alpana Agrawal, Aditi Sharma, Pritee Singh, Arti Garg, Smiley Kushwaha, Ramesh Kumar Jain, Suresh Kumar Indian Dermatol Online J Brief Report INTRODUCTION: Leprosy or Hansen's disease poses a drastic impact on the quality of life in affected patients even after successful completion of treatment. The involvement of the endocrine system in leprosy is usually insidious, silent, and under-reported, especially the testicular dysfunction. AIMS AND OBJECTIVES: The present study was aimed at evaluating the abnormalities of the primary testicular hormone testosterone and the gonadotrophins LH and FSH in male patients affected with lepromatous leprosy and assessing the impact of the disease on quality of life (QOL). MATERIALS AND METHODS: The study included 43 married male patients diagnosed with lepromatous leprosy. Careful history taking and examination for symptoms of testicular dysfunction were done. Serum concentrations of total testosterone, FSH, and LH were noted. The QOL was evaluated using the WHO Quality of Life-BREF (WHOQoL-BREF). RESULTS: The most common clinical manifestation of testicular dysfunction was reduced or loss of libido reported in 12 (27.9%) patients followed by gynaecomastia in 7 (16.3%). Ultrasonographic (USG) analysis revealed reduced testicular volume in 31 (72.1%) patients, and average testicular volume was 11.9 ± 4.9 mL each. Seventeen (39.5%) patients had low serum testosterone levels, 9 (20.9%) had high serum FSH level, and 11 (25.6%) high LH levels. There was a significant negative correlation between testosterone level and FSH as well as LH. There was also a significantly positive correlation between testicular volume and testosterone level. Symptomatic patients with gynaecomastia/gynaecothelia had higher hormonal derangement than those who had other symptoms. On QOL, most patients scored lowest on the domain of “social relationships” (including sexual wellbeing) followed by “psychological health”. CONCLUSION: We found a high rate of USG diagnosed testicular atrophy in lepromatous leprosy patients. Therefore, every leprosy patient should be thoroughly examined clinically to rule out features of testicular dysfunction. Testicular function tests should be routinely carried out in all leprosy patients to arrive at an early diagnosis. Leprosy is found to affect all domains of a patient's quality of life. Wolters Kluwer - Medknow 2020-09-19 /pmc/articles/PMC7735009/ /pubmed/33344347 http://dx.doi.org/10.4103/idoj.IDOJ_287_20 Text en Copyright: © 2020 Indian Dermatology Online Journal http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Brief Report
Mohta, Alpana
Agrawal, Aditi
Sharma, Pritee
Singh, Arti
Garg, Smiley
Kushwaha, Ramesh Kumar
Jain, Suresh Kumar
Endocrinological Testicular Dysfunction in Patients with Lepromatous Leprosy and the Impact of Disease on Patient's Quality of Life
title Endocrinological Testicular Dysfunction in Patients with Lepromatous Leprosy and the Impact of Disease on Patient's Quality of Life
title_full Endocrinological Testicular Dysfunction in Patients with Lepromatous Leprosy and the Impact of Disease on Patient's Quality of Life
title_fullStr Endocrinological Testicular Dysfunction in Patients with Lepromatous Leprosy and the Impact of Disease on Patient's Quality of Life
title_full_unstemmed Endocrinological Testicular Dysfunction in Patients with Lepromatous Leprosy and the Impact of Disease on Patient's Quality of Life
title_short Endocrinological Testicular Dysfunction in Patients with Lepromatous Leprosy and the Impact of Disease on Patient's Quality of Life
title_sort endocrinological testicular dysfunction in patients with lepromatous leprosy and the impact of disease on patient's quality of life
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735009/
https://www.ncbi.nlm.nih.gov/pubmed/33344347
http://dx.doi.org/10.4103/idoj.IDOJ_287_20
work_keys_str_mv AT mohtaalpana endocrinologicaltesticulardysfunctioninpatientswithlepromatousleprosyandtheimpactofdiseaseonpatientsqualityoflife
AT agrawaladiti endocrinologicaltesticulardysfunctioninpatientswithlepromatousleprosyandtheimpactofdiseaseonpatientsqualityoflife
AT sharmapritee endocrinologicaltesticulardysfunctioninpatientswithlepromatousleprosyandtheimpactofdiseaseonpatientsqualityoflife
AT singharti endocrinologicaltesticulardysfunctioninpatientswithlepromatousleprosyandtheimpactofdiseaseonpatientsqualityoflife
AT gargsmiley endocrinologicaltesticulardysfunctioninpatientswithlepromatousleprosyandtheimpactofdiseaseonpatientsqualityoflife
AT kushwaharameshkumar endocrinologicaltesticulardysfunctioninpatientswithlepromatousleprosyandtheimpactofdiseaseonpatientsqualityoflife
AT jainsureshkumar endocrinologicaltesticulardysfunctioninpatientswithlepromatousleprosyandtheimpactofdiseaseonpatientsqualityoflife